Why is On­col­o­gy Drug De­vel­op­ment Re­search Late to the Dig­i­tal Bio­mark­ers Game?

4 years ago

Mol­e­c­u­lar Di­ag­nos­tics Can Trans­form Can­cer Care. Let’s Make It Hap­pen.

4 years ago

Sci­pher Med­i­cine trans­lates com­plex bi­ol­o­gy to pre­dict bet­ter out­comes

4 years ago

Un­lock­ing ESG strate­gies for growth with Gilead Sci­ences

4 years ago

In­side Track: Be­hind the Scenes of a Ma­jor Biotech SPAC

4 years ago

How Mul­ti-Stake­hold­er Strate­gies for Ex­ter­nal Con­trol Arms Can Over­come Ap­proval and Ac­cess Bar­ri­ers

5 years ago

Mov­ing Out of the Clin­ic with Dig­i­tal Tools: Mo­bile Spirom­e­try Dur­ing COVID-19 & Be­yond

5 years ago

How Pa­tients with Epilep­sy Ben­e­fit from Re­al-World Da­ta

5 years ago

The DCT-OS: A Tech­nol­o­gy-first Op­er­at­ing Sys­tem - En­abling Clin­i­cal Tri­als

5 years ago

We need faster end­points for tar­get­ed can­cer drugs – here’s one we can use

5 years ago

Qual­i­ty Con­trol in Cell and Gene Ther­a­py – What’s Re­al­ly at Stake?

5 years ago

BY­OD Best Prac­tices: How Mo­bile De­vice Strat­e­gy Leads to More Pa­tient-Cen­tric Clin­i­cal Tri­als

5 years ago

Can we cre­ate a world free of pain?

5 years ago

Start­ing your clin­i­cal jour­ney with the end in mind – the val­ue of a drug de­vel­op­ment plan

5 years ago

From Clin­i­cal Strat­e­gy to De­vel­op­ment: Nav­i­gat­ing COVID-19 to Sup­port the Next Gen­er­a­tion of Pa­tient-Fo­cused Treat­ments

5 years ago

Top Five Rules for Suc­cess in De­cen­tral­ized Tri­als

5 years ago

Ac­cel­er­at­ing drug de­vel­op­ment with­out sac­ri­fic­ing safe­ty: How phar­ma­covig­i­lance is keep­ing pace with COVID-19 clin­i­cal re­search

5 years ago

Tar­get­ing a Po­ten­tial Vul­ner­a­bil­i­ty of Cer­tain Can­cers with DNA Dam­age Re­sponse

5 years ago

Forg­ing an In­no­v­a­tive Path in CNS Treat­ment

5 years ago

Is Aus­tralia the next Glob­al Des­ti­na­tion for Phase 2?

5 years ago

Vi­da Ven­tures: Pow­er­ing Break­throughs in Bio­phar­ma

5 years ago

Da­ta Lit­er­a­cy: The Foun­da­tion for Mod­ern Tri­al Ex­e­cu­tion

5 years ago

5AM Ven­tures: Fu­el­ing the Next Gen­er­a­tion of In­no­va­tors

5 years ago

I-Mab —A Biotech on the Rise with In­spired Sci­ence

5 years ago
First page Previous page 45678910 Next page Last page
A service from the Financial Times